Listar por autor "Marín, Francisco"
Mostrando ítems 1-19 de 19
-
Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry
Bertomeu-González, Vicente; Moreno-Arribas, José; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Raña-Míguez, Paula; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory; Marín, Francisco (NLM, 2019-12-24)[Abstract] Background. Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral ... -
Cardiopatía estructural en pacientes anticoagulados con fibrilación auricular no valvular: prevalencia y perfil clínico en una muestra nacional
Ruiz Ortiz, Martín; Roldán, Inmaculada; Bertomeu, Vicente; Muñiz, Javier; Marín, Francisco; Anguita, Manuel (Sociedad Española de Cardiología, 2016-07-21) -
Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study
Moreno-Arribas, José; Bertomeu-González, Vicente; Anguita, Manuel; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (SAGE, 2015-07-30)[Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ... -
Current antiarrhythmic therapy for nonvalvular atrial fibrillation in Spain: data from the FANTASIIA registry
Roldán, Inmaculada; Anguita, Manuel; Marín, Francisco; Quesada, María Angustias; Camacho Siles, José; Peinado, Rafael; Bertomeu, Vicente; Cequier, Ángel; Badimón, Lina; Muñiz, Javier (Elsevier, 2015-06-18)[Abstract] Introduction and objectives. Recently, there have been many developments in the management of nonvalvular atrial fibrillation, antiarrhythmic and anticoagulant therapy, and nonpharmacological treatment, but these ... -
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study
Ruiz Ortiz, Martín; Muñiz, Javier; Esteve-Pastor, María Asunción; Marín, Francisco; Roldán, Inmaculada; Cequier, Ángel; Martínez-Sellés, Manuel; González Saldivar, Hugo; Bertomeu, Vicente; Anguita, Manuel (SAGE, 2020-03-31)[Abstract] Objective: To describe major events at follow up in octogenarian patients with atrial fibrillation (AF) according to anticoagulant treatment: direct oral anticoagulants (DOACs) versus vitamin K antagonists ... -
Do physicians correctly calculate thromboembolic risk scores?: a comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores
Esteve-Pastor, María Asunción; Marín, Francisco; Bertomeu-Martínez, Vicente; Roldán, Inmaculada; Cequier, Ángel; Badimón, Lina; Muñiz, Javier; Valdés, Mariano; Anguita, Manuel (Wiley, 2016-03-01)[Abstract] BACKGROUND: Clinical risk scores, CHADS2 and CHA2 DS2 -VASc scores, are the established tools for assessing stroke risk in patients with atrial fibrillation (AF). AIM: The aim of this study is to assess concordance ... -
Impact of integrated care management on clinical outcomes in atrial fibrillation patients: a report from the FANTASIIA Registry
Esteve-Pastor, María Asunción; Ruiz-Ortiz, Martín; Muñiz, Javier; Roldán Rabadán, Inmaculada; Otero García, Deborah; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y. H.; Marín, Francisco (Frontiers, 2022-05)[Abstract] Background: An integrated and holistic approach is increasingly advocated in patients with atrial fibrillation (AF), based on the “Atrial fibrillation Better Care (ABC) pathway: A, Avoid stroke with anticoagulation; ... -
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study
Roldán Rabadán, Inmaculada; Esteve-Pastor, María Asunción; Anguita, Manuel; Muñiz, Javier; Ruiz Ortiz, Martín; Marín, Francisco; Roldán, Vanessa; Quesada, María Angustias; Camacho Siles, José; Cequier Fillat, Angel; Bertomeu-Martínez, Vicente; Martínez-Sellés, Manuel; Badimón, Lina (Elsevier, 2020-04-14)[Abstract] Background: While many risk factors for Atrial Fibrillation (AF) have been identified, there are important differences in their relative impact between sexes. The aim of our study was to investigate the influence ... -
La INR durante los ictus y las hemorragias en pacientes con fibrilación auricular tratados con antagonistas de la vitamina K
Anguita, Manuel; Anguita Gámez, María; Bertomeu, Vicente; Ruiz Ortiz, Martín; Cequier, Ángel; Roldán, Inmaculada; Muñiz, Javier; Esteve-Pastor, María Asunción; Vivas Balcones, David; Marín, Francisco; Pérez-Villascastín, Julián (Elsevier, 2020-07)[Resumen] Introducción y objetivos. La fibrilación auricular tiene un mal pronóstico asociado fundamentalmente al desarrollo de ictus. A pesar del uso de anticoagulantes, algunos pacientes pueden sufrir ictus y también ... -
Oral anticoagulation in octogenarians with atrial fibrillation
González Saldivar, Hugo; Figueiras-Graillet, Lourdes M.; Anguita, Manuel; Marín, Francisco; Bertomeu, Vicente; Roldán, Inmaculada; Ruiz, Martín; Muñiz, Javier; Martínez-Sellés, Manuel (Elsevier, 2016-08-08)[Abstract] Background. Vitamin K antagonists (VKAs) are still largely employed, even in nonvalvular atrial fibrillation (AF). Our aim was to study the clinical profile of octogenarians treated with oral anticoagulation ... -
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry
Bertomeu-González, Vicente; Moreno-Arribas, José; Esteve-Pastor, María Asunción; Roldán-Rabadán, Inmaculada; Muñiz, Javier; Otero García, Deborah; Ruiz-Ortiz, Martín; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y.H.; Marín, Francisco (Wiley, 2020-10-16)[Abstract] Background: Atrial fibrillation (AF) and peripheral artery disease (PAD) are common conditions that increase cardiovascular risk. We determined the association between PAD and prognosis in a cohort of real-world ... -
Predictive value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre spanish observational registry FANTASIIA
Marín, Francisco; Roldán, Vanessa; Bertomeu-González, Vicente; Cequier, Ángel; Muñiz, Javier; Roldán, Inmaculada; Bertomeu-Martínez, Vicente; Badimón, Lina; Lip, Gregory; Anguita, Manuel (Oxford, 2015) -
Quality of anticoagulation with vitamin K antagonists
Bertomeu-González, Vicente; Anguita, Manuel; Moreno-Arribas, José; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (Wiley, 2015-05-11)[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ... -
Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: data from FANTASIIA Registry
Roldán Rabadán, Inmaculada; Esteve-Pastor, María Asunción; Anguita, Manuel; Muñiz, Javier; Camacho Siles, José; Quesada, María Angustias; Ruiz Ortiz, Martín; Marín, Francisco; Martínez-Sellés, Manuel; Bertomeu, Vicente; Lip, Gregory; Cequier Fillat, Angel; Badimón, Lina (Wiley, 2018-02-09)[Abstract] Background. Anticoagulation control in patients with atrial fibrillation (AF) has a multidisciplinary approach although is usually managed by general practitioners (GP) or haematologists. The aim of our study ... -
Relationship between multimorbidity and outcomes in atrial fibrillation
Proietti, Marco; Esteve-Pastor, María Asunción; Rivera-Caravaca, José Miguel; Roldán, Vanessa; Roldán Rabadán, Inmaculada; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y.H.; Marín, Francisco (Elsevier, 2021-07-23)[Abstract] Background: Multimorbidity is common in atrial fibrillation (AF) patients. Charlson comorbidity index (CCI) is used to evaluate multimorbidity in the general population. Limited long-term data are available on ... -
Relationship of Adverse Events to Quality of Anticoagulation Control in Atrial Fibrillation Patients With Diabetes: Real-World Data From the FANTASIIA Registry
García-Fernández, Amaya; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Otero, Déborah; Anguita, Manuel; Lip, Gregory; Marín, Francisco (Taylor & Francis Group, 2020-06-17)[Abstract] Background: Atrial fibrillation (AF) patients with diabetes (DM) have high risk of cardiovascular events. Purpose: To compare clinical characteristics, adverse outcomes and quality of anticoagulation in AF ... -
Satisfaction with medical care in patients with atrial fibrillation treated with vitamin k antagonists versus new oral anticoagulants
Anguita, Manuel; Marín, Francisco; Roldán, Inmaculada; Cequier, Ángel; Bertomeu, Vicente; Muñiz, Javier (Elsevier, 2015-04-27) -
Structural heart disease in anticoagulated patients with nonvalvular atrial fibrillation: prevalence and clinical profile in a spanish sample
Ruiz Ortiz, Martín; Roldán, Inmaculada; Bertomeu, Vicente; Muñiz, Javier; Marín, Francisco; Anguita, Manuel (Elsevier, 2016-07-27) -
Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation
Rivera-Caravaca, José Miguel; Marín, Francisco; Esteve-Pastor, María Asunción; Raña-Míguez, Paula; Anguita, Manuel; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Valdés, Mariano; Vicente, Vicente; Lip, Gregory; Roldán, Vanessa (Elsevier, 2017-09-19)[Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...
